New study could pave the way for Huntington's disease therapies

The progressive neurodegenerative disorder affects about one in 10,000 people in the UK.

Related Keywords

Babraham ,Cambridgeshire ,United Kingdom ,Cambridge ,Sarah Tabrizi ,Joseph Hamilton ,Rob Goold ,University Of Cambridge ,Huntington Disease Centre ,Queen Square Institute Of Neurology ,Babraham Research Campus ,United Kingdom Dementia Research Institute ,Square Institute ,Adrestia Therapeutics ,Professor Sarah Tabrizi ,Disease Centre ,Cell Reports ,United Kingdom Dementia Research ,